School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Structure Therapeutics Inc. GPCR

Healthcare · Biotechnology

$25.54last close 2026-10-09 · market cap $1.82B · delayed data

Trailing returns

1M-38.05%
3M-53.68%
6M-53.68%
1Y-16.40%

Basis: Adjusted daily closes.

What it does

Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.

Open GPCR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies